Background
The scope of pharmacist services for patients with pulmonary disease has primarily focused on drug related outcomes; however pharmacists have the ability to broaden the scope of clinical services by performing diagnostic testing including quality spirometry testing. Studies have demonstrated that pharmacists can perform quality spirometry testing based upon international guidelines.
Aim of the review
The primary aim of this review was to assess the published evidence of pharmacists performing quality spirometry testing based upon American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines. In order to accomplish this, the description of evidence and type of outcome from these services were reviewed.
Methods
A literature search was conducted using five databases [PubMed (1946–January 2015), International Pharmaceutical Abstracts (1970 to January 2015), Cumulative Index of Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews] with search terms including pharmacy, spirometry, pulmonary function, asthma or COPD was conducted. Searches were limited to publications in English and reported in humans. In addition, Uniform Resource Locators and Google Scholar searches were implemented to include any additional supplemental information.
Results
Eight studies (six prospective multi-center trials, two retrospective single center studies) were included. Pharmacists in all studies received specialized training in performing spirometry testing. Of the eight studies meeting inclusion and exclusion criteria, 8 (100 %) demonstrated acceptable repeatability of spirometry testing based upon standards set by the ATS/ERS guidelines. Acceptable repeatability of seven studies ranged from 70 to 99 % consistent with published data.
Conclusion
Available evidence suggests that quality spirometry testing can be performed by pharmacists. More prospective studies are needed to add to the current evidence of quality spirometry testing performed by pharmacists and to measure health outcomes of the pulmonary patient.
Similar content being viewed by others
References
Levy ML, Quanjer PH, Booker R, Cooper BG, Holmes S, Small IR. Diagnostic spirometry in primary care. Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations. Primary Care Respir J. 2009;18(3):130–47.
Crapo RO. Pulmonary function testing. N Engl J Med. 1994;331(1):25–30.
Kaminsky DA, Marcy TW, Bachand M, Irvin CG. Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care. 2005;50(12):1639–48.
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.
Crapo RO, Hankinson JL, Irvin C, MacIntyre NR, Voter KZ, Wise RA, et al. Standardization of spirometry 1994 update. Am J Respir Crit Care Med. 1995;152:1107–36.
Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the national Lung health Education Program. Respir Care. 2000;45(5):513–30.
Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD. A meta analysis. Chest. 2004;125(6):2309–21.
Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventative Services Task Force recommendation statement. Ann Intern Med. 2008;148(7):535–43.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2014. [cited 2015 April 6]. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf.
National Heart, Lung and Blood Institute. Expert panel report 3: guidelines for the diagnosis and management of asthma. [cited 2015 April 9]. http://www.nhlbi.nih.gov/files/docs/guidelines/asthgdln.pdf.
Lusuardi M, De Benedetto F, Paggiaro P, et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in asthma and COPD: a comparative evaluation Italian study. Chest. 2006;129(4):844–52.
Mikhail MN, Catania PN. Using a hand-held spirometer as a monitoring tool in chronic theophylline therapy. Drug Intell Clin Pharm. 1987;21(6):502–4.
DeTullio PL, Corson ME. Effect of pharmacist counseling on ambulatory patients’ use of aerosolized bronchodilators. Am J Hosp Pharm. 1987;44(8):1802–6.
Emmerton LM, Smith L, LeMay KS, Krass I, Saini B, Bosnic-Anticevich SZ et al. Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Services Research 2012;12:164. [cited 2015 May 1]. http://www.biomedcentral.com/content/pdf/1472-6963-12-164.pdf.
Gibson P, Henry D, Francis L, Cruickshank D, Dupen F, Higginbotham N, et al. Association between availability of non-prescription B2 agonist inhalers and undertreatment of asthma. BMJ. 1993;306:1514–8.
Stergachis A, Gardner JS, Anderson MT, Sullivan SD. Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference? J Am Pharm Assoc. 1996;42(5):743–52.
Solidoro P, Braido F, Baratta F, Bagnasco D, Esposito R, Aggeri M, et al. FEV6 assessment in spirometric abnormalities screening: the first population-based study in Italian pharmacies. Panminerva Med. 2013;55(1):87–92.
Gissing PM, Burton DL, Simpson MD, Burton MA, Bowman SL. Pharmaceutical care: impact on asthma medication use. J Pharm Pract Res. 2004;34:26–9.
Midodzi WK, Mayers I, Rowe B, Vathanayagam D, Chan M, Alwashmi M, et al. Validity of the Piko-6 portable device for screening for obstructive airways disease in a community pharmacy practice. American Thoracic Society International Conference. Poster B45. [cited 2015 May 3]. http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A2846.
Hackbarth D, Cohen RA, Preckwinkel L, Younker L, McKee C, Solinski J, et al. Spirometry screening and an invitation to quit from a state tobacco quit line as motivators for smoking cessation among community dwelling adults. Chest. 2006;130:145S-a.
Stratton TP, Williams RG, Meine KL. Developing a mobile pharmacist-conducted wellness clinic for rural Montana communities. J Am Pharm Assoc. 2005;45(3):390–9.
Simpson M, Burton D, Burton M, Bowman S. Impact of spirometry on pharmacists decision to refer. Australian Pharm. 2005;24(12):964–8.
Kennedy DT, Paulson DM, Eddy TD, Patel PC, Patkar AD, Holdford DA, et al. A smoking-cessation program consisting of extensive counseling, pharmacotherapy, and office spirometry: results of a pilot project in a veterans administration medical center. Pharmacotherapy. 2004;24(10):1400–7.
Mann RP, Zaiken K. Management of chronic obstructive pulmonary disease by pharmacists in an internal medicine department. Am J Health Syst Pharm. 2009;66(10):890–3.
Wright D, Twigg M, Thornley T. Chronic obstructive pulmonary disease case findings by community pharmacists: a potential cost-effective public health intervention. Int J Pharm Pract. 2015;23:83–5.
Corlett SA, Howes K, Salter M, Krska J Evaluation of a community pharmacy spirometry testing service for current and recent ex-smokers. In: 9th pharmaceutical care network Europe working conference 2015. Abstract #32. [cited 2015 April 22]. http://www.pcne.org/script25.php?abstractid=32.
Burton D, Simpson M, Wettenhall J, Armour C, Bosnic-Anticevitch S, Saini B, et al. Acceptability and utility of spirometry measurements in the pharmacy asthma care program. In: 2006 annual scientific meetings, the thoracic society of Australia and New Zealand and The Australian and New Zealand Society of Respiratory Science, Western Australia: Asian Pacific Society of Respirology. [cited 2015 April 8]. http://www.nddmed.com/downloads/Download_00132_00.pdf.
Castillo D, Guayta R, Giner J, Burgos F, Capdevila C, Soriano JB, et al. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. Respir Med. 2009;103:839–45.
Burton MA, Burton DL, Simpson MD, Gissing PM, Bowman SL. Respiratory function testing: the impact of respiratory scientists on the training and support of primary health care providers. Respirology. 2004;9:260–4.
Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, et al. Pharmacy asthma care program (PACP) improves outcomes for patients in the community. Thorax. 2007;62:496–502.
Burton DL, LeMay KS, Saini B, Smith L, Bosnic-Anticevich S, Southwell P, et al. The reliability and utility of spirometry performed on people with asthma in community pharmacies. J Asthma. 2015;7:1–27.
Fuller L, Conrad WF, Heaton PC, Panos R, Eschenbacher W, Frede SM. Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting. J Am Pharm Assoc. 1012;52:e59–66.
Licskai CJ, Sands TW, Paolatto L, Nicoletti I, Ferrone M. Spirometry in primary care: an analysis of spirometry test quality in a regional primary care asthma program. Can Respir J. 2012;19:249–54.
Cawley MJ, Pacitti R, Warning W. Assessment of a pharmacist-driven point-of-care spirometry clinic within a primary care physicians office. Pharm Pract. 2011;4:221–7.
Willey VJ, Simon S, Akkineni S, Reinhold J, Kelly BL, Kim EA, et al. Preliminary evaluation of comprehensive pharmacist-led services to patients with respiratory diseases within a community-based medical home. Value Health. 2013;16:A198.
The Global Asthma Report (2014) [cited May 6, 2015]. http://www.globalasthmareport.org/burden/burden.php.
World Health Organization. Chronic respiratory diseases. Burdon of COPD, [cited May 2, 2015]. http://www.who.int/respiratory/copd/burden/en/.
Han MK, Kim MG, Mardon R, Rennner P, Sullivan S, Diette GB, et al. Spirometry utilization for COPD: how do we measure up? Chest. 2007;132(2):403–9.
Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola Espana PP, et al. Predictors of mortality in patients with stable COPD. J Gen Intern Med. 2008;23(11):1829–34.
Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG. Mortality in GOLD stages of COLD and its dependence on symptoms of chronic bronchitis. Respir Res. 2005;6(1):98. doi:10.1186/1465-9921-6-98.
Yawn BP, Enright PL, Lemanske RF, Isreal E, Pace W, Wollan P, et al. Spirometry can be done in family physicians’ offices and alters clinical decisions in management of asthma and COPD. Chest. 2007;132(4):1162–8.
Enright PL, Skloot GW, Cox-Ganser JM, Udasin IG, Herbert R. Quality of spirometry performed by 13,599 participants in the world trade center worker and volunteer medical screening program. Respir Care. 2010;55(3):303–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The authors did not receive funding support for this project.
Conflicts of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Cawley, M.J., Warning, W.J. Pharmacists performing quality spirometry testing: an evidence based review. Int J Clin Pharm 37, 726–733 (2015). https://doi.org/10.1007/s11096-015-0160-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-015-0160-x